Pettinga Financial Advisors’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$202K	Sell	1,275 -3,886	-75%	-$525K	0.03%	148
2026 Q1	$659K	Sell	5,161 -9,355	-64%	-$1.17M	0.12%	91
2025 Q4	$1.77M	Sell	14,516 -4,024	-22%	-$461K	0.34%	52
2025 Q3	$1.86M	Buy	18,540 +795	+4%	+$71.6K	0.36%	51
2025 Q2	$1.47M	Sell	17,745 -10,915	-38%	-$871K	0.32%	50
2025 Q1	$2.32M	Sell	28,660 -245	-0.8%	-$21.9K	0.55%	43
2024 Q4	$2.6M	Buy	28,905 +3,297	+13%	+$319K	0.59%	40
2024 Q3	$2.53M	Sell	25,608 -1,025	-4%	-$101K	0.6%	35
2024 Q2	$2.47M	Buy	26,633 +193	+0.7%	+$17.3K	0.62%	36
2024 Q1	$2.51M	Sell	26,440 -405	-2%	-$37.6K	0.64%	38
2023 Q4	$2.4M	Buy	26,845 +8,030	+43%	+$596K	0.64%	39
2023 Q3	$1.37M	Buy	18,815 +475	+3%	+$37.9K	0.42%	40
2023 Q2	$1.53M	Sell	18,340 -870	-5%	-$72.8K	0.45%	38
2023 Q1	$1.46M	Buy	19,210 +960	+5%	+$79.7K	0.46%	38
2022 Q4	$1.51M	Sell	18,250 -2,020	-10%	-$164K	0.49%	39
2022 Q3	$1.61M	Buy	20,270 +3,295	+19%	+$278K	0.55%	37
2022 Q2	$1.26M	Buy	16,975 +4,525	+36%	+$340K	0.38%	45
2022 Q1	$1.12M	Buy	12,450 +1,985	+19%	+$183K	0.28%	52
2021 Q4	$1.17M	Buy	10,465 +4,823	+85%	+$582K	0.28%	54
2021 Q3	$709K	Buy	+5,642	New	+$727K	0.18%	61
2020 Q2	–	Sell	-7,070	Closed	-$548K	–	85
2020 Q1	$548K	Buy	+7,070	New	+$626K	0.37%	40
2019 Q4	–	Sell	-13,875	Closed	-$1.06M	–	93
2019 Q3	$1.06M	Buy	13,875 +10,325	+291%	+$858K	0.57%	37
2019 Q2	$311K	Buy	+3,550	New	+$303K	0.16%	75
2019 Q1	–	Sell	-9,000	Closed	-$646K	–	102
2018 Q4	$646K	Buy	+9,000	New	+$725K	0.42%	37